Compare companies
Six facts from the filings for each company in a group, then what each says about a topic in its latest 10-K.
Health care: the same six facts for each company
- Sales growth
- +11%
- Net margin
- 2.1%
- Debt / equity
- 0.68
- Accounting items to read
- 0 of 4
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +12%
- Net margin
- 3.5%
- Debt / equity
- 0.71
- Accounting items to read
- 1 of 5
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +7.8%
- Net margin
- 2.6%
- Debt / equity
- 0.75
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 1
- Big investors holding
- 0
- Sales growth
- +12%
- Net margin
- 1.1%
- Debt / equity
- -
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +9.3%
- Net margin
- 0.8%
- Debt / equity
- 3.93
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +14%
- Net margin
- 0.7%
- Debt / equity
- -
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +19%
- Net margin
- 0.7%
- Debt / equity
- 0.70
- Accounting items to read
- 1 of 3
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +12%
- Net margin
- 2.5%
- Debt / equity
- 0.69
- Accounting items to read
- 0 of 3
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +10%
- Net margin
- 0.8%
- Debt / equity
- 0.66
- Accounting items to read
- 1 of 4
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +6.0%
- Net margin
- 16%
- Debt / equity
- 0.55
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +45%
- Net margin
- 32%
- Debt / equity
- 1.23
- Accounting items to read
- 3 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +7.1%
- Net margin
- 8.6%
- Debt / equity
- -
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
All 60 companies in Health care
- Sales growth
- +1.3%
- Net margin
- 3.6%
- Debt / equity
- 1.20
- Accounting items to read
- 2 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +8.6%
- Net margin
- 16%
- Debt / equity
- -
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- -1.6%
- Net margin
- 6.3%
- Debt / equity
- 0.70
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- -0.2%
- Net margin
- 18%
- Debt / equity
- 1.86
- Accounting items to read
- 0 of 5
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +5.7%
- Net margin
- 9.7%
- Debt / equity
- 0.61
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +3.9%
- Net margin
- 15%
- Debt / equity
- 0.79
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +10.0%
- Net margin
- 24%
- Debt / equity
- 3.76
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +8.4%
- Net margin
- 14%
- Debt / equity
- 0.56
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +2.4%
- Net margin
- -12%
- Debt / equity
- 2.01
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +11%
- Net margin
- 14%
- Debt / equity
- 0.61
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +2.9%
- Net margin
- 17%
- Debt / equity
- 0.53
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +8.2%
- Net margin
- 4.2%
- Debt / equity
- 0.69
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +4.8%
- Net margin
- 10.0%
- Debt / equity
- 0.86
- Accounting items to read
- 2 of 5
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +20%
- Net margin
- 17%
- Debt / equity
- 0.47
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 1
- Big investors holding
- 0
- Sales growth
- +9.7%
- Net margin
- 8.0%
- Debt / equity
- 0.75
- Accounting items to read
- 0 of 5
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +5.9%
- Net margin
- 8.1%
- Debt / equity
- 2.41
- Accounting items to read
- 0 of 5
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +1.0%
- Net margin
- 29%
- Debt / equity
- 0.06
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- -3.0%
- Net margin
- -4.1%
- Debt / equity
- 0.97
- Accounting items to read
- 0 of 5
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +7.2%
- Net margin
- 6.9%
- Debt / equity
- 0.66
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +6.5%
- Net margin
- 6.5%
- Debt / equity
- -
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +4.0%
- Net margin
- 3.1%
- Debt / equity
- 1.12
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +8.9%
- Net margin
- 31%
- Debt / equity
- 0.22
- Accounting items to read
- 4 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +12%
- Net margin
- 9.5%
- Debt / equity
- 0.73
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +5.7%
- Net margin
- -6.2%
- Debt / equity
- 1.45
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +21%
- Net margin
- 26%
- Debt / equity
- -
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +2.2%
- Net margin
- 3.4%
- Debt / equity
- 0.39
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +2.3%
- Net margin
- 26%
- Debt / equity
- 2.74
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +7.2%
- Net margin
- 9.0%
- Debt / equity
- 0.59
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +0.9%
- Net margin
- 1.9%
- Debt / equity
- 0.95
- Accounting items to read
- 2 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +6.7%
- Net margin
- 20%
- Debt / equity
- 0.54
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +12%
- Net margin
- 15%
- Debt / equity
- 0.06
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +8.7%
- Net margin
- 13%
- Debt / equity
- 0.26
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +21%
- Net margin
- 6.7%
- Debt / equity
- -
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +9.9%
- Net margin
- 28%
- Debt / equity
- 0.07
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +7.0%
- Net margin
- 1.8%
- Debt / equity
- 0.34
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +16%
- Net margin
- 19%
- Debt / equity
- -
- Accounting items to read
- 2 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +10%
- Net margin
- 25%
- Debt / equity
- 0.20
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- -0.7%
- Net margin
- 20%
- Debt / equity
- 0.57
- Accounting items to read
- 2 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +5.1%
- Net margin
- 13%
- Debt / equity
- 0.31
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 5
- Big investors holding
- 0
- Sales growth
- +4.0%
- Net margin
- 22%
- Debt / equity
- -
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +0.9%
- Net margin
- 12%
- Debt / equity
- -
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- -0.9%
- Net margin
- 1.0%
- Debt / equity
- 0.76
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 1
- Big investors holding
- 0
- Sales growth
- +16%
- Net margin
- 29%
- Debt / equity
- -
- Accounting items to read
- 0 of 5
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +6.3%
- Net margin
- 19%
- Debt / equity
- 0.07
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- +31%
- Net margin
- 13%
- Debt / equity
- 0.61
- Accounting items to read
- 1 of 4
- Insider buys, 90 days
- 1
- Big investors holding
- 0
- Sales growth
- +3.7%
- Net margin
- 8.6%
- Debt / equity
- 0.36
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- -40%
- Net margin
- -110%
- Debt / equity
- 0.09
- Accounting items to read
- 1 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
- Sales growth
- -0.4%
- Net margin
- 14%
- Debt / equity
- 0.18
- Accounting items to read
- 0 of 6
- Insider buys, 90 days
- 0
- Big investors holding
- 0
Crypto: paragraphs that mention it
What the companies wrote
CI Cigna Group
1 paragraph… other global organizations, where this individual defined information security strategies; built global information security programs; implemented cybersecurity capabilities that protect consumers, wholesale partners and brands; and oversaw the security of a global payment network, a corporate network and digital assets.
10-K, 10-K Feb 26, 2026 ↗VEEV VEEVA SYSTEMS INC
1 paragraph• Veeva PromoMats is an end-to-end content and digital asset management (“DAM”) solution through which life sciences companies can collaborate, review, distribute, and update commercial content and manage assets. PromoMats also includes integrated AI Agents that assist with document review.
10-K, 10-K Mar 20, 2026 ↗A AGILENT TECHNOLOGIES, INC.
0 paragraphsNot mentioned in the latest 10-K.
ABBV AbbVie Inc.
0 paragraphsNot mentioned in the latest 10-K.
ABT ABBOTT LABORATORIES
0 paragraphsNot mentioned in the latest 10-K.
ACAD ACADIA PHARMACEUTICALS INC
0 paragraphsNot mentioned in the latest 10-K.
Show all 76 companies' quotes
ACHC Acadia Healthcare Company, Inc.
0 paragraphsNot mentioned in the latest 10-K.
ADMA ADMA BIOLOGICS, INC.
0 paragraphsNot mentioned in the latest 10-K.
ADUS Addus HomeCare Corp
0 paragraphsNot mentioned in the latest 10-K.
AGIO AGIOS PHARMACEUTICALS, INC.
0 paragraphsNot mentioned in the latest 10-K.
ALGN ALIGN TECHNOLOGY INC
0 paragraphsNot mentioned in the latest 10-K.
ALKS Alkermes plc.
0 paragraphsNot mentioned in the latest 10-K.
ALNY ALNYLAM PHARMACEUTICALS, INC.
0 paragraphsNot mentioned in the latest 10-K.
AMGN AMGEN INC
0 paragraphsNot mentioned in the latest 10-K.
AMRX Amneal Pharmaceuticals, Inc.
0 paragraphsNot mentioned in the latest 10-K.
AXSM Axsome Therapeutics, Inc.
0 paragraphsNot mentioned in the latest 10-K.
BAX BAXTER INTERNATIONAL INC
0 paragraphsNot mentioned in the latest 10-K.
BBIO BridgeBio Pharma, Inc.
0 paragraphsNot mentioned in the latest 10-K.
BCRX BIOCRYST PHARMACEUTICALS INC
0 paragraphsNot mentioned in the latest 10-K.
BDX BECTON DICKINSON & CO
0 paragraphsNot mentioned in the latest 10-K.
BEAM Beam Therapeutics Inc.
0 paragraphsNot mentioned in the latest 10-K.
BHC Bausch Health Companies Inc.
0 paragraphsNot mentioned in the latest 10-K.
BIIB BIOGEN INC.
0 paragraphsNot mentioned in the latest 10-K.
BKD Brookdale Senior Living Inc.
0 paragraphsNot mentioned in the latest 10-K.
BMRN BIOMARIN PHARMACEUTICAL INC
0 paragraphsNot mentioned in the latest 10-K.
BMY BRISTOL MYERS SQUIBB CO
0 paragraphsNot mentioned in the latest 10-K.
BSX BOSTON SCIENTIFIC CORP
0 paragraphsNot mentioned in the latest 10-K.
BTSG BrightSpring Health Services, Inc.
0 paragraphsNot mentioned in the latest 10-K.
CAH CARDINAL HEALTH INC
0 paragraphsNot mentioned in the latest 10-K.
CNC CENTENE CORP
0 paragraphsNot mentioned in the latest 10-K.
COO COOPER COMPANIES, INC.
0 paragraphsNot mentioned in the latest 10-K.
COR Cencora, Inc.
0 paragraphsNot mentioned in the latest 10-K.
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
0 paragraphsNot mentioned in the latest 10-K.
CVS CVS HEALTH Corp
0 paragraphsNot mentioned in the latest 10-K.
DGX QUEST DIAGNOSTICS INC
0 paragraphsNot mentioned in the latest 10-K.
DHR DANAHER CORP /DE/
0 paragraphsNot mentioned in the latest 10-K.
DVA DAVITA INC.
0 paragraphsNot mentioned in the latest 10-K.
DXCM DEXCOM INC
0 paragraphsNot mentioned in the latest 10-K.
ELV Elevance Health, Inc.
0 paragraphsNot mentioned in the latest 10-K.
EW Edwards Lifesciences Corp
0 paragraphsNot mentioned in the latest 10-K.
GEHC GE HealthCare Technologies Inc.
0 paragraphsNot mentioned in the latest 10-K.
GILD GILEAD SCIENCES, INC.
0 paragraphsNot mentioned in the latest 10-K.
HCA HCA Healthcare, Inc.
0 paragraphsNot mentioned in the latest 10-K.
HSIC HENRY SCHEIN INC
0 paragraphsNot mentioned in the latest 10-K.
HUM HUMANA INC
0 paragraphsNot mentioned in the latest 10-K.
IDXX IDEXX LABORATORIES INC /DE
0 paragraphsNot mentioned in the latest 10-K.
ILMN ILLUMINA, INC.
0 paragraphsNot mentioned in the latest 10-K.
INCY INCYTE CORP
0 paragraphsNot mentioned in the latest 10-K.
IQV IQVIA HOLDINGS INC.
0 paragraphsNot mentioned in the latest 10-K.
ISRG INTUITIVE SURGICAL INC
0 paragraphsNot mentioned in the latest 10-K.
JNJ JOHNSON & JOHNSON
0 paragraphsNot mentioned in the latest 10-K.
LH LABCORP HOLDINGS INC.
0 paragraphsNot mentioned in the latest 10-K.
LLY ELI LILLY & Co
0 paragraphsNot mentioned in the latest 10-K.
MCK MCKESSON CORP
0 paragraphsNot mentioned in the latest 10-K.
MDT Medtronic plc
0 paragraphsNot mentioned in the latest 10-K.
MRK Merck & Co., Inc.
0 paragraphsNot mentioned in the latest 10-K.
MRNA Moderna, Inc.
0 paragraphsNot mentioned in the latest 10-K.
MTD METTLER TOLEDO INTERNATIONAL INC/
0 paragraphsNot mentioned in the latest 10-K.
PFE PFIZER INC
0 paragraphsNot mentioned in the latest 10-K.
PODD INSULET CORP
0 paragraphsNot mentioned in the latest 10-K.
REGN REGENERON PHARMACEUTICALS, INC.
0 paragraphsNot mentioned in the latest 10-K.
RMD RESMED INC
0 paragraphsNot mentioned in the latest 10-K.
RVTY REVVITY, INC.
0 paragraphsNot mentioned in the latest 10-K.
SOLV Solventum Corp
0 paragraphsNot mentioned in the latest 10-K.
STE STERIS plc
0 paragraphsNot mentioned in the latest 10-K.
SYK STRYKER CORP
0 paragraphsNot mentioned in the latest 10-K.
TECH BIO-TECHNE Corp
0 paragraphsNot mentioned in the latest 10-K.
TMO THERMO FISHER SCIENTIFIC INC.
0 paragraphsNot mentioned in the latest 10-K.
UHS UNIVERSAL HEALTH SERVICES INC
0 paragraphsNot mentioned in the latest 10-K.
UNH UNITEDHEALTH GROUP INC
0 paragraphsNot mentioned in the latest 10-K.
VRTX VERTEX PHARMACEUTICALS INC / MA
0 paragraphsNot mentioned in the latest 10-K.
VTRS Viatris Inc
0 paragraphsNot mentioned in the latest 10-K.
WAT WATERS CORP /DE/
0 paragraphsNot mentioned in the latest 10-K.
WST WEST PHARMACEUTICAL SERVICES INC
0 paragraphsNot mentioned in the latest 10-K.
ZBH ZIMMER BIOMET HOLDINGS, INC.
0 paragraphsNot mentioned in the latest 10-K.
ZTS Zoetis Inc.
0 paragraphsNot mentioned in the latest 10-K.